Эксклюзивный дистрибьютор в РУз
ООО "Medilife-Farma"
+998 78 120 67 20
ООО "Medilife-Farma"
+998 78 120 67 20
Flaminal® o‘zi nima?
Flaminal ® - o‘tkir va surunkali yaralarni, shuningdek, infeksiyalangan yaralarni* yoki infeksiya xavfi bo‘lgan yaralarni davolash uchun innovatsion yara bitqazuvchi vositadir
* mutaxassis nazorati ostida
Flaminal® Hydro
Kam yoki o‘rtacha suyuqlik ajralishi mumkin bolgan jarohatlar uchun
Flaminal® Forte
O‘rtacha yoki yuqori suyuqlik ajralishi mumkin bolgan jarohatlar uchun
Yuqori alginat miqdori
Kam alginat miqdori
Tozalaydi
Flaminal® nekrotik to‘qimalar va fibrinoz birikmalarni eritadi 1,4.
Infeksiya bilan kurashmoqda
I
Flaminal® ortiqcha suyuqlikni o'ziga yutadi5 va quruq yaralarni namlantiradi
Nam muhitni saqlaydi
Flaminal® infeksiyalar va bioplyonkalar hosil bo‘lishidan himoya qiladi1,4.
M
Flaminal® epitelizatsiya va yarani bitishni tezlashtiradi
Davolaydi
E
Flaminal® абсорбирует избыточный экссудат5.
Абсорбирующий альгинат
Flaminal® qanday ishlaydi?
T - Tissue (to'qimalar)
T
M
M - Moisture balance
(namlikni saqlab turish)
(namlikni saqlab turish)
E
E - Epithelial advancement
(epitelizatsiyaning yaxshilanishi)
(epitelizatsiyaning yaxshilanishi)
I - Infection (infeksiya)/
Inflamination (yallig‘lanish)
Inflamination (yallig‘lanish)
Yaralarni davolashning xalqaro standartiga (TIME) mos keladi
Jarohatlarni davolash uchun universal vosita
Flaminal® tarkibida mikroblarga qarshi ferment tizimi mavjud bo‘lib, u hujayralarning o‘sishiga to‘sqinlik qilmasdan jarohatlarning bitishiga yordam beradi.
Flaminal® mikroblarni yo‘q qiladi va bakteriyalar sonini kamaytiradi. Alginat ortiqcha suyuqlikni so‘rib olib, tuzalish uchun zarur bo‘lgan namlikni saqlab turadi.
Flaminal® jarohatni doimiy ravishda tozalaydi
Flaminal® mikroblarni yo‘q qiladi va bakteriyalar sonini kamaytiradi. Alginat ortiqcha suyuqlikni so‘rib olib, tuzalish uchun zarur bo‘lgan namlikni saqlab turadi.
Flaminal® jarohatni doimiy ravishda tozalaydi
Universal
jarohat turlari va shakllarining keng doirasi uchun mos keladi
oson surtiladi va ba’zi jarohatlarni mustaqil davolash uchun mos keladi
Oddiy
Kompleksli
TIMES yaralarni baholashning barcha jihatlarini, shu jumladan infeksiyalarni davolash va oldini olishni qamrab oladi
bog‘lamlarni og‘riqsiz yangilashni ta’minlaydi
Atravmatik
Xavfsiz
teri va jarohat to‘qimalarining sog‘lom hujayralari uchun zararli emas
bemorlar va tibbiyot xodimlarining vaqtini tejagan holda bir nechta mahsulotlardan foydalanish zaruratini bartaraf etadi
Tejamli
Davolash
yaralarning tez bitishiga yordam beradi
barcha yosh guruhlari uchun mos
Har qanday yosh
Nimaga Flaminal®?
Qanday ishlatiladi?
1-qadam
Mahalliy qoidalarga amal qilib, jarohatni tozalang
2-qadam
Flaminal® surtib, jarohatning barcha o‘rinlarini qalin qatlam (taxminan 4-5 mm) bilan qoplang
3-qadam
Flaminal ® ustiga ikkilamchi bog‘lam qo‘ying
Klinik holatlar
Ссылки:
1. McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. (2023) Etiology, Epidemiology,
and Disparities in the Burden of Diabetic Foot Ulcers. Diabetes Care. 2023 Jan
1;46(1):209-221. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797649/ (accessed
May 2024).
2. Edmonds M, Manu C, & Vas P. (2021) The current burden of diabetic foot disease.
Journal of Clinical Orthopaedics and Trauma. (17): 88-93. https://www.ncbi.
nlm.nih.gov/pmc/articles/PMC7919962/pdf/main.pdf (accessed May 2024).
3. Kerr M, Barron E, Chadwick P, Evans T, Kong M, Rayman G, Sutton-Smith M, Todd G,
Young B, Jeffcoate W.J. (2019). The cost of diabetic foot ulcers and amputations to the
National Health Service in England. Diabetic Medicine. Diabetes UK. https://onlinelibrary.
wiley.com/doi/10.1111/dme.13973 (accessed May 2024).
Подробная информация
1. McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW. (2023) Etiology, Epidemiology,
and Disparities in the Burden of Diabetic Foot Ulcers. Diabetes Care. 2023 Jan
1;46(1):209-221. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797649/ (accessed
May 2024).
2. Edmonds M, Manu C, & Vas P. (2021) The current burden of diabetic foot disease.
Journal of Clinical Orthopaedics and Trauma. (17): 88-93. https://www.ncbi.
nlm.nih.gov/pmc/articles/PMC7919962/pdf/main.pdf (accessed May 2024).
3. Kerr M, Barron E, Chadwick P, Evans T, Kong M, Rayman G, Sutton-Smith M, Todd G,
Young B, Jeffcoate W.J. (2019). The cost of diabetic foot ulcers and amputations to the
National Health Service in England. Diabetic Medicine. Diabetes UK. https://onlinelibrary.
wiley.com/doi/10.1111/dme.13973 (accessed May 2024).
Подробная информация
Кейс №1
Aisling Brereton
Diabetic Podiatrist, Queen Elizabeth Hospital, Gayton Road, Kings Lynn, PE30 4ET. Tel: 01553 613613. Email: aisling.brereton@qehkl.nhs.uk
Кейс №2
1. lnternational Diabetes Federation, 2017 Diabetes Atlas (eighth edn.)
2. Leone S, Pascale R, Vitale M et al (2012) Epidemiology of diabetic foot. lnfez Med 20 Suppll: 8-13
3. Frog FR, Peach G, Price P et al (2012) Measures of health-related quality of life in diabetes-related foot disease: a systematic review. Diabetalogia 55: 552-65
4. Bakker K, Apleqvist J, Lipsky BA et al (2016) The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an
evidence-based global consensus. Diabetes Metab Res Rev 32 (Suppl 1 ): 2-6
5. Prompers L, Schaper N, Apelqvist J et al (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 51 (5): 747-755
6. Armstrong DG, Boulton AJM, Bus SA (2017) Diabetic foot ulcers and their recurrence. N Engl J Med, 376: 2637-75
7. De Smet K, Van den Plas D, Lens D, Sollie P {2009) Pre-clinical evaluation of a new antimicrobial enzyme for the control of wound bioburden. Wounds 21 (3): 65-73
8.International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers. Wounds International, 2013. Available from: www.woundsinternational.com
Подробная информация
Aisling Brereton
Diabetic Podiatrist, Queen Elizabeth Hospital, Gayton Road, Kings Lynn, PE30 4ET. Tel: 01553 613613. Email: aisling.brereton@qehkl.nhs.uk
Кейс №2
1. lnternational Diabetes Federation, 2017 Diabetes Atlas (eighth edn.)
2. Leone S, Pascale R, Vitale M et al (2012) Epidemiology of diabetic foot. lnfez Med 20 Suppll: 8-13
3. Frog FR, Peach G, Price P et al (2012) Measures of health-related quality of life in diabetes-related foot disease: a systematic review. Diabetalogia 55: 552-65
4. Bakker K, Apleqvist J, Lipsky BA et al (2016) The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an
evidence-based global consensus. Diabetes Metab Res Rev 32 (Suppl 1 ): 2-6
5. Prompers L, Schaper N, Apelqvist J et al (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 51 (5): 747-755
6. Armstrong DG, Boulton AJM, Bus SA (2017) Diabetic foot ulcers and their recurrence. N Engl J Med, 376: 2637-75
7. De Smet K, Van den Plas D, Lens D, Sollie P {2009) Pre-clinical evaluation of a new antimicrobial enzyme for the control of wound bioburden. Wounds 21 (3): 65-73
8.International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers. Wounds International, 2013. Available from: www.woundsinternational.com
Подробная информация
Ссылки:
Кейс №1
Подробная информация
Кейс №1
- Public Health England (2015) Guidance Pressure ulcers: applying All Our Health Dealey, C. Posnett, J. & Walker, A (2012) The cost of pressure ulcers in the United Kingdom. Journal of Wound Care. 21 (6). PP 261-62, 264, 266.
- National Pressure Ulcer Advisory Panel (2014) Prevention and Treatment of Pressure Ulcers: Quick reference guide.
- Mervis JS, Phillips TJ. (2019) Pressure ulcers: Pathophysiology, epidemiology, risk factors, and presentation. J Am Acad Dermatol. Oct;81(4):881-890
- Onigbinde, AT. Ogunsanya, GI & Oniyangi SO. (2012) Pressure ulcer incidence among high-risk inpatients in Nigeria. British Journal of Nursing (Tissue Viability Supplement) Vol 12, No12. ppS4-S.
- NHS England & NHS Improvement (2019). Pressure Ulcer Categories.
- Wounds UK (2012) Wound Essentials. Effective compression therapy – how to guide. Vol 7. Issue 2
Подробная информация
Ссылки:
Кейс №1
Кейс №2
Кейс №1
- Shim T, Minhas S, Muneer A, Bunker B. (2014) Atypical Presentation of Genital Herpes Simplex (HSV-2) in Two Patients with Chronic Lymphocytic Leukemia. Acta Derm Venereal 94: 246-247.
- De la Brassinne M, Thirion L, Horvat LI. (2006) A novel method of comparing the healing properties of two hydrogels in chronic leg ulcers. J Eur Acad Dermatol Venereal. 20(2): 131-35.
- White R. (2006) Flaminal: a novel approach to wound bioburden control. Wounds UK 2 (3): 64-9.
Кейс №2
- MacCara ME. (1983) Extravasation. A hazard of intravenous therapy. Drug Intelligence and Clinical Pharmacy. 17(10): 713-717.
- Wilkens CE, Emmerson AJB. (2004) Extravasation injuries on regional neonatal units. Arch Dis Child Fetal Neonatal Ed. 89: F274-F275.
- Fox MD. (2011) Wound care in the neonatal intensive care unit. Neonatal Netw 30: 291. [PubMed]
- Durante CM. (2012) An open label non-comparative case series on the efficacy of an enzyme alginogel. Journal of Wound Care 21 (1): 22-26.
Ссылки:
Подробная информация
- Hope V, Kimber J, Vickerman P, Hickman M, Ncube F (2008) Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England BMC Infect Dis 81:20
- Acquaro J (2012) Managing a chronic wound in a heroin user Wounds International 3 (4): 24-25
- Murphy EL, DeVita D, Liu H et al (2001) Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis 33: 35-40
- White R (2006) Flaminal: a novel approach to wound bioburden control. Wounds UK 2 (3): 64-9
- Medlin S (2012) Nutrition for wound healing BJN (Suppl) 21 (12): S11-15
- Kean J (2010) Effects of smoking on the wound healing process. JWC 19 (1)
Подробная информация
Ссылки:
1. Pillay E. Epidermolysis bullosa. Br J Nurs 2003 Oct; 12(19 Suppl):S43.
2. 1 Ly L, Su JC. Dressings used in epidermolysis bullosa blister wounds: a review. J Wound Care 2008 Nov;17(11):482, 484-6, 488.
3. de la Brassine M, Thirion L, Horvat LI. A novel method of comparing the healing properties of two hydrogels in chronic leg ulcers. J Eur Acad Dermatol Venereol 2006 Feb;20(2):131-5.
Подробная информация
1. Pillay E. Epidermolysis bullosa. Br J Nurs 2003 Oct; 12(19 Suppl):S43.
2. 1 Ly L, Su JC. Dressings used in epidermolysis bullosa blister wounds: a review. J Wound Care 2008 Nov;17(11):482, 484-6, 488.
3. de la Brassine M, Thirion L, Horvat LI. A novel method of comparing the healing properties of two hydrogels in chronic leg ulcers. J Eur Acad Dermatol Venereol 2006 Feb;20(2):131-5.
Подробная информация
Saytda ishlatilgan havolalar:
- De Smet, K. et al. Pre-clinical evaluation of a new antimicrobial enzyme for the control of wound bioburden. Wounds. 2009, 21(3): 65 - 73.
- Jones, J. et al. TIME to assess wounds - a clinical evaluation of FLAMINAL® (ZEIT für die Bewertung von Wunden - eine klinische Evaluierung von FLAMINAL®) Wounds UK. 2018, 14(3): 63 - 69.
- White, R, Linssen, E: Wundbettvorbereitung, T.I.M.E. und ein Enzym-Alginogel: Literaturübersicht und die klinische Praxis. Wund Management 2016, 10(2), 87 - 90.
- Cooper RA (2013) Inhibition of biofilms by glucose oxidase, lactoperoxidase and guaiacol: the active antibacterial component in an enzyme alginogel. Int Wound J 10(6): 630–7.
- Flenhealth.co.uk. 2021. Instruction For Use.
- Flen Health. Data on File. Internal Report: Evaluation of Fluid Absorption Capacity and Antimicrobial Activity of Aquacel products. 2017.
Takrorlanadigan savollar
Agar savolingizga javob topa olmagan bo‘lsangiz, quyidagi havola orqali bizga murojaat qiling
Bu har qanday jarohatni davolash uchun mos keladigan noyob yara bitkazuvchi vositadir.
- Flaminal ® Forte - agar jarohatda suyuqlik ko‘p bo‘lsa (ko‘proq alginat saqlaydi va o‘rtacha va ko‘p miqdorda ekssudatsiya bo‘lgan jarohatlarda qo‘llanilishi kerak)
- Flaminal ® Hydro - agar yara quruq yoki biroz nam bo‘lsa (kamroq alginatni o‘z ichiga oladi va oz yoki o‘rtacha ekssudat ajralishi bo‘lgan yaralarda ishlatilishi kerak)
- Jarohat va uning atrofini yaxshilab yuvib, tozalang.
- Flaminal ® (Hydro yoki Forte) ni qalin qatlam bilan (masalan, 4-5 mm) surting.
- Ikkilamchi bog‘lam bilan yoping.
- Flaminal® (Hydro & Forte) gelning tuzilishi butun bo‘lmay qolganda (1-4 kundan keyin, suyuqligi miqdoriga qarab) yangilanadi.
- Dastlab yara kattaroq ko‘rinishi mumkin; bu o‘lik to‘qimalarning so‘rilishini keltirib chiqaradigan Flaminal ® (Hydro & Forte) tozalash ta’sirining normal natijasidir.
- Alginatlar (gel) ning rangi ularning tabiiy kelib chiqishi tufayli biroz o‘zgarishi mumkin. Rangning o‘zgarishi Flaminal ® (Hydro yoki Forte) sifatiga ta’sir qilmaydi. Quruq mumsimon parchalar (alginat parchalar) ko‘rinishi mumkin. Agar ular yaraning chetida bo‘lsa, bu normal holat, chunki ular yarani matseratsiyadan himoya qiladi.
- Agar parchalar yaraning o‘zida paydo bo‘lsa, ayniqsa Flaminal ® Forte ishlatilganda, bu yaraning yetarli darajada suyuqlik ishlab chiqarmasligi bilan bog‘liq bo‘lishi mumkin va siz Flaminal ® Hydro ga o‘tishingiz kerak.
Jarohat Flaminal ® Hydro uchun juda nam va uni ko‘proq shimish qobiliyatiga ega bo‘lgan Flaminal ® Forte bilan almashtirish kerak. Ikkilamchi bog‘lamning so'rilishiga ishonch hosil qiling.
Ha. Flaminal ® tarkibida ikkita ferment, glyukozooksidaza va laktoperoksidaza mavjud. Glyukozooksidaza mavjud glyukoza, kislorod va suvni peroksid ionlariga aylantiradi. Laktoperoksidaza peroksid ionlarini kislorodning faol shakllariga aylantiradi. Yaratilgan kislorodning faol shakllari Flaminal ® matritsasida so‘rilgan bakteriyalarni yo‘q qiladi. Flaminalning antimikrob ta’sir mexanizmi faqat matritsada mavjud.
Flaminal ® (Hydro & Forte) yaradagi bakterial muvozanatni tiklaydi va nekrotik materialni uzluksiz olib tashlash orqali yaraning tabiiy bitishini ta’minlaydi. Agar jarohat infeksiya yoki ishqalanish bilan bog‘liq bo‘lmagan sabablarga ko‘ra qayta granulyatsiyaga uchrasa, Flaminal® (Hydro & Forte) dan foydalanishni to‘xtating va hujayralar o‘sishini kamaytirish uchun jarohatni quruq saqlang. Jarohat o‘rnidagi mahalliy bosim ham granulyatsiyani kamaytirishga yordam beradi.
Telefonlar
Barcha savol va takliflaringizga javob berishga tayyormiz!
Siz bilan bog‘lanishimiz uchun kontaktlaringizni qoldiring.
Yoki ko‘rsatilgan telefon raqamlari yoki pochta orqali murojaat qiling.
Barcha savol va takliflaringizga javob berishga tayyormiz!
Siz bilan bog‘lanishimiz uchun kontaktlaringizni qoldiring.
Yoki ko‘rsatilgan telefon raqamlari yoki pochta orqali murojaat qiling.
O‘zbekistondagi Ekskluziv distribyutor
"Medilife-Farma" MCHJ
Toshkent sh., Yakkasaroy tumani,
Muqimiy ko‘chasi, 22, Diabet markazi
+998 (78) 120-67-20 (19)
medilife@inbox.ru
"Medilife-Farma" MCHJ
Toshkent sh., Yakkasaroy tumani,
Muqimiy ko‘chasi, 22, Diabet markazi
+998 (78) 120-67-20 (19)
medilife@inbox.ru
